Welcome to our dedicated page for OneMedNet news (Ticker: ONMD), a resource for investors and traders seeking the latest updates and insights on OneMedNet stock.
OneMedNet Corp provides healthcare data and software solutions focused on regulatory-grade, AI-ready real-world data for life sciences, medical device, research, and AI customers. Company news commonly centers on the OneMedNet iRWD™ platform, its Palantir Foundry-powered search and data access capabilities, and the commercialization of subscription-based real-world data products.
Recurring developments include platform launches, bookings and revenue updates, data licensing agreements, and collaborations that expand disease-specific and multimodal datasets. Recent company updates have discussed oncology, autoimmune, neurotechnology, medical imaging, electronic health records, longitudinal patient data, cohort discovery, and real-world evidence generation.
OneMedNet (Nasdaq: ONMD), a leader in regulatory-grade Real World Data (RWD), has joined the Amazon Web Services (AWS) Partner Network (APN) and secured a new client, a computational biotechnology organization, through the AWS Marketplace.
The APN is a global community leveraging AWS programs and resources to build, market, and sell offerings.
OneMedNet President and CEO Aaron Green highlighted the anticipated rapid growth and the advantages of being part of the APN, emphasizing access to comprehensive clinical data via the iRWD™ network.
The new client praised the ease of accessing OneMedNet's curated clinical data through the AWS Marketplace, enhancing their research and development capabilities.
OneMedNet announced a three-year Master Services Agreement with a top-10 global medical technology company, impacting over 150 million patients annually.
The agreement leverages OneMedNet's iRWD™ platform to securely de-identify, search, and curate regulatory-grade clinical data.
This deal highlights growing industry adoption of OneMedNet's platform and aims to enhance the customer's competitive positioning through better-informed decision-making.
OneMedNet announced a significant expansion of its iRWD™ network and platform, boasting a more than five-fold increase.
The company has partnered with new entities, including a nationwide medical records custodian, increasing its network to 1,402 healthcare system and provider partner sites, 31 million patients, and 121.4 million clinical exams.
This growth represents a 472% increase in partner sites, a 170% rise in patients, and a 122% bump in clinical exams since the end of 2023.
CEO Aaron Green emphasized that this expansion aligns with OneMedNet's strategy to leverage real-world data for healthcare innovation.
OneMedNet , a leading curator of precision curated regulatory-grade Real World Data, will participate in the EF Hutton Annual Global Conference on May 15, 2024. The company's President & CEO and Founder & CMO will be presenting at the event, with management holding one-on-one investor meetings.
OneMedNet (Nasdaq: ONMD) has joined ClinEco Inc., a platform that enhances access and distribution for clinical research. This move validates OneMedNet's Real World Data platform within the clinical trial ecosystem. Aaron Green, President and CEO of OneMedNet, expressed excitement at becoming part of this community. ClinEco serves as a networking hub for clinical trial stakeholders, fostering collaboration and innovation in the life sciences sector.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.